Looking at the researchers:
It's good to hear @DMissa's comments about the primary author. Here's an article about her. She's had experience with engineered muscle tissue experiments before.
The senior author is at ICREA and looks to have been working with engineered tissue for a long time. He has a number of publications about muscle diseases, muscle dystrophy. The researcher we know interested in FSHD genetics might know something about this team.
Seeing Jesus Castro-Marrero on the author list rang a few alarm bells, as we have seen some less than great research from him, with some concerns about management of conflicts of interest in relation to supplement manufacturers. But here, it looks as though he was not involved in the analysis. It's possible that he was brought in as the ME/CFS expert and didn't have much involvement.
I like the background of some of the authors, in rare diseases and inherited metabolic disorders and muscular diseases. The funding sources looked fine. Some of the work associated with Professor Morten hasn't had quite the level of rigour that I would have liked to have seen. I guess though, the number of academics I'd like to see as referees of ME/CFS research is unfortunately very small.
It would be great if our Spanish members or others who know this team could give us some more background. Even better if the researchers would like to come to the forum to talk about their work. I hope that they won't be put off by the scrutiny, it's a protective mechanism, we don't want to get too excited. We are looking for the problems.
If replicated, these findings could be very important. It would be wonderful to have validation for the odd feeling of intermittent loss of power in muscles.
I wonder what the researchers are planning to do next.
It's good to hear @DMissa's comments about the primary author. Here's an article about her. She's had experience with engineered muscle tissue experiments before.
The senior author is at ICREA and looks to have been working with engineered tissue for a long time. He has a number of publications about muscle diseases, muscle dystrophy. The researcher we know interested in FSHD genetics might know something about this team.
Seeing Jesus Castro-Marrero on the author list rang a few alarm bells, as we have seen some less than great research from him, with some concerns about management of conflicts of interest in relation to supplement manufacturers. But here, it looks as though he was not involved in the analysis. It's possible that he was brought in as the ME/CFS expert and didn't have much involvement.
I like the background of some of the authors, in rare diseases and inherited metabolic disorders and muscular diseases. The funding sources looked fine. Some of the work associated with Professor Morten hasn't had quite the level of rigour that I would have liked to have seen. I guess though, the number of academics I'd like to see as referees of ME/CFS research is unfortunately very small.
It would be great if our Spanish members or others who know this team could give us some more background. Even better if the researchers would like to come to the forum to talk about their work. I hope that they won't be put off by the scrutiny, it's a protective mechanism, we don't want to get too excited. We are looking for the problems.
If replicated, these findings could be very important. It would be wonderful to have validation for the odd feeling of intermittent loss of power in muscles.
I wonder what the researchers are planning to do next.